NYSE · TRIS
Tristar Acquisition I Corp.
$11.47+$0.48 (+4.37%)
Tristar Acquisition I Corp.’s quoted price sits in the upper half of its reported 52-week range, 4.5% below the high.
Loading market information…
NASDAQ · EBAC · USD
Stock price
Quote as of Mar 2, 2023, 09:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
European Biotech Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 20.64% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
European Biotech Acquisition Corp. (EBAC) is presently not engaged in substantial business operations. Instead, its core purpose is to facilitate a business combination, potentially through a merger, share exchange, asset acquisition, share purchase, or reorganization, with one or more other companies or organizations. The firm was established in 2021 and its headquarters are located in Amsterdam, the Netherlands.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:25 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$11.47+$0.48 (+4.37%)
Tristar Acquisition I Corp.’s quoted price sits in the upper half of its reported 52-week range, 4.5% below the high.
$10.44+$0.01 (+0.1%)
G Squared Ascend II Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.69% below the high.
$6.15-$0.26 (-4.06%)
Bridgetown Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 41.04% below the high.
$12.02+$0.58 (+5.07%)
SK Growth Opportunities Corporation’s quoted price sits in the upper half of its reported 52-week range, 10.3% below the high.
$11.45-$0.01 (-0.04%)
AP Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 7.77% below the high.
$9.95-$0.05 (-0.5%)
Parabellum Acquisition Corp.: Financial Services · Shell Companies.
$0.74+$0.01 (+0.68%)
Zapata Quantum, Inc.’s quoted price sits in the lower half of its reported 52-week range, 68.72% below the high.
$5.01-$0.10 (-1.88%)
Direxion Daily COIN Bull 2X ETF’s quoted price sits in the lower half of its reported 52-week range, 82.33% below the high.
